Harrow (HROW) Current Deferred Revenue (2010 - 2026)
Harrow (HROW) posted quarterly Current Deferred Revenue of $149000.0 for Q1 2026, up 2.76% year-over-year from $145000.0 in Q1 2025, and down 81.09% quarter-over-quarter from $788000.0 in Q4 2025.
Harrow (HROW) Current Deferred Revenue (2010 - 2026) Analysis & Trends
Harrow's Current Deferred Revenue history runs 13 years deep, the most recent figure standing at $149000.0 for Q1 2026.
- In Q1 2026, Current Deferred Revenue rose 2.76% year-over-year to $149000.0; the TTM figure through Mar 2026 stood at $149000.0 (up 2.76% YoY), while the FY2025 annual figure was $788000.0, up 1690.91% from the prior year.
- Current Deferred Revenue for Q1 2026 stood at $149000.0, down from $788000.0 in the prior quarter.
- The five-year high for Current Deferred Revenue was $788000.0 in Q4 2025, with the low at $23000.0 in Q1 2022.
- The 5-year median for Current Deferred Revenue is $115000.0 (2022), against an average of $165882.4.
- The sharpest annual moves came in 2022 and 2025: Current Deferred Revenue surged 3733.33% in 2022, then plunged 63.31% in 2025.
- Harrow's Current Deferred Revenue stood at $113000.0 in 2022, then tumbled by 33.63% to $75000.0 in 2023, then slumped by 41.33% to $44000.0 in 2024, then surged by 1690.91% to $788000.0 in 2025, then sank by 81.09% to $149000.0 in 2026.
- Business Quant data shows HROW's Current Deferred Revenue at $149000.0 in Q1 2026, $788000.0 in Q4 2025, and $345000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Harrow | 1.56 Bn | 1.47 Bn | 50.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 106,000.00 |
| Mar 31, 2026 | 149,000.00 |
| Dec 31, 2025 | 788,000.00 |
| Sep 30, 2025 | 345,000.00 |
| Jun 30, 2025 | 91,000.00 |
| Mar 31, 2025 | 145,000.00 |
| Dec 31, 2024 | 44,000.00 |
| Sep 30, 2024 | 137,000.00 |
| Jun 30, 2024 | 248,000.00 |
| Mar 31, 2024 | 112,000.00 |
| Dec 31, 2023 | 75,000.00 |
| Sep 30, 2023 | 153,000.00 |
| Jun 30, 2023 | 132,000.00 |
| Mar 31, 2023 | 67,000.00 |
| Dec 31, 2022 | 113,000.00 |
| Sep 30, 2022 | 115,000.00 |
| Jun 30, 2022 | 83,000.00 |
| Mar 31, 2022 | 23,000.00 |
| Dec 31, 2021 | 16,000.00 |
| Sep 30, 2021 | 3,000.00 |